Publication | Closed Access

Clinicopathological significance of aberrant methylation of RARβ2 at 3p24, RASSF1A at 3p21.3, and FHIT at 3p14.2 in patients with non-small cell lung cancer

Tumor BiologyAberrant MethylationClinicopathological SignificanceMedicinePathologyCancer Cell BiologyCancer GenomicsCancer BiologyMolecular DiagnosticsCancer GeneticsOncologyCell BiologyLung CancerCancer Research